Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma

被引：1
|
作者：
Kocher, Florian [1 ]
Seeber, Andreas [1 ]
机构：
[1] Med Univ Innsbruck, Comprehens Canc Ctr Innsbruck, Dept Internal Med Hematol & Oncol 5, Anichstr 35, A-6020 Innsbruck, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 03期
关键词：
Head and neck squamous cell carcinoma (HNSCC); Palliative first-line tratment; Recent trials; Treatment algorithm; OPEN-LABEL; PLUS PACLITAXEL; METASTATIC HEAD; PEMBROLIZUMAB; CETUXIMAB; CHEMOTHERAPY; RECURRENT; FLUOROURACIL; KEYNOTE-048; MULTICENTER;
D O I：
10.1007/s12254-023-00901-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This short review gives an overview of current treatment concepts, recently published trials, and novel developments in relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) not amendable for local curative treatment. Trials with potential future clinical implications and relevant updates of landmark trials are provided as well.
引用
收藏
页码：176 / 179
页数：4
相关论文
共 50 条
  • [1] Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma
    Florian Kocher
    Andreas Seeber
    memo - Magazine of European Medical Oncology, 2023, 16 : 176 - 179
  • [2] Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Borcoman, Edith
    Marret, Gregoire
    Le Tourneau, Christophe
    CANCERS, 2021, 13 (11)
  • [3] Efficacy of first-line systemic treatment regimens for recurrent/metastatic head and neck squamous cell carcinoma: a network meta-analysis
    Yu, Xiao
    Su, Xiaolei
    Fang, Ling
    Zhang, Honglei
    Chen, Xi
    Pu, Yu
    Liu, Hongyi
    Guo, Rui
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (03) : 1391 - 1401
  • [4] Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study
    Liu, Yizhen
    Xue, Liqiong
    Xia, Zuguang
    Zhang, Qunling
    Guo, Ye
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (09): : 2040 - 2045
  • [5] New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma
    Gibson, Michael K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 579 - 582
  • [6] Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma
    Weiss, Jared M.
    Bagley, Stephen
    Hwang, Wei-Ting
    Bauml, Joshua
    Olson, Juneko Grilley
    Cohen, Roger B.
    Hayes, David Neil
    Langer, Corey
    CANCER, 2016, 122 (15) : 2350 - 2355
  • [7] Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States
    Borse, Rebekah H.
    Ramakrishnan, Karthik
    Gandhi, Jyotika
    Dhankhar, Praveen
    Chirovsky, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 954 - 965
  • [8] Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
    Haddad, Robert I.
    Harrington, Kevin
    Tahara, Makoto
    Ferris, Robert L.
    Gillison, Maura
    Fayette, Jerome
    Daste, Amaury
    Koralewski, Piotr
    Zurawski, Bogdan
    Taberna, Miren
    Saba, Nabil F.
    Mak, Milena
    Kawecki, Andrzej
    Girotto, Gustavo
    Alvarez Avitia, Miguel Angel
    Even, Caroline
    Toledo, Joaquin Gabriel Reinoso
    Guminski, Alexander
    Muller-Richter, Urs
    Kiyota, Naomi
    Roberts, Mustimbo
    Khan, Tariq Aziz
    Miller-Moslin, Karen
    Wei, Li
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) : 2166 - +
  • [9] Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina
    Wurcel, Victoria
    Chirovsky, Diana
    Borse, Rebekah
    Altuna, Juan Ignacio
    Carabajal, Fernando
    Gandhi, Jyotika
    ADVANCES IN THERAPY, 2021, 38 (05) : 2613 - 2630
  • [10] Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study
    Demirci, Nebi Serkan
    Aksoy, Sercan
    Ozdemir, Nuriye Yildirim
    Erdem, Gokmen Umut
    Ozcelik, Melike
    Tanrikulu, Eda
    Eren, Tulay
    Bozkaya, Yakup
    Sahin, Suleyman
    Basol, Fatma
    Aslan, Suheyla Aytac
    Zengin, Nurullah
    Gullu, Ibrahim
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 401 - 407
12345